Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Chinese Patent Office
Cantor Fitzgerald
Queensland Health
Argus Health
Johnson and Johnson
Fish and Richardson

Generated: October 17, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202871

« Back to Dashboard
NDA 202871 describes METOPROLOL TARTRATE, which is a drug marketed by Mylan, Gland Pharma Ltd, Luitpold, Sagent Strides, Watson Labs, Hospira, Teva Pharms, Aurobindo Pharma, Teva, Sun Pharm Inds Inc, Fresenius Kabi Usa, Baxter Hlthcare Corp, Prinston Inc, Sun Pharm Inds, Apothecon, Ipca Labs Ltd, Sandoz Inc, Hikma Farmaceutica, Alembic Pharms Ltd, Purepac Pharm, Rubicon Res Pvt Ltd, Sandoz, and West-ward Pharms Int, and is included in thirty-four NDAs. It is available from sixty-four suppliers. Additional details are available on the METOPROLOL TARTRATE profile page.

The generic ingredient in METOPROLOL TARTRATE is hydrochlorothiazide; metoprolol tartrate. There are thirty-one drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; metoprolol tartrate profile page.

Summary for NDA: 202871

Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 202871

Mechanism of ActionAdrenergic beta-Antagonists

Suppliers and Packaging for NDA: 202871

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
metoprolol tartrate
TABLET;ORAL 202871 ANDA Major Pharmaceuticals 0904-6340 0904-6340-60 100 TABLET in 1 BOTTLE (0904-6340-60)
metoprolol tartrate
TABLET;ORAL 202871 ANDA Major Pharmaceuticals 0904-6340 0904-6340-61 100 BLISTER PACK in 1 CARTON (0904-6340-61) > 1 TABLET in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG
Approval Date:May 28, 2013TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG
Approval Date:May 28, 2013TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength100MG
Approval Date:May 28, 2013TE:ABRLD:No

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
US Department of Justice
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus